• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨甲他汀片段的合成及其组蛋白去乙酰化酶和抗肿瘤活性的测定。

Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.

作者信息

Fennell Kelley A, Miller Marvin J

机构信息

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.

出版信息

Org Lett. 2007 Apr 26;9(9):1683-5. doi: 10.1021/ol070382e. Epub 2007 Mar 31.

DOI:10.1021/ol070382e
PMID:17397173
Abstract

[reaction: see text] Amamistatins A and B are natural products found to have anti-proliferative effects against MCF-7, A549, and MKN45 human tumor cell lines (IC50 0.24-0.56 microM). It was proposed that their activity was due to histone deacetylase (HDAC) inhibition mediated by the N-formyl-N-hydroxy lysine moiety. Amamistatin B fragment analogs were synthesized and screened for biological activity. These compounds were modest HDAC inhibitors and showed antitumor activity against MCF-7 and PC-3 human tumor cells.

摘要

[反应:见正文] 氨甲他汀A和B是天然产物,已发现它们对MCF-7、A549和MKN45人肿瘤细胞系具有抗增殖作用(IC50为0.24 - 0.56微摩尔)。有人提出它们的活性归因于由N-甲酰基-N-羟基赖氨酸部分介导的组蛋白脱乙酰酶(HDAC)抑制作用。合成了氨甲他汀B片段类似物并对其进行生物活性筛选。这些化合物是适度的HDAC抑制剂,并对MCF-7和PC-3人肿瘤细胞显示出抗肿瘤活性。

相似文献

1
Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.氨甲他汀片段的合成及其组蛋白去乙酰化酶和抗肿瘤活性的测定。
Org Lett. 2007 Apr 26;9(9):1683-5. doi: 10.1021/ol070382e. Epub 2007 Mar 31.
2
Syntheses and biological activity of amamistatin B and analogs.氨甲他汀B及其类似物的合成与生物活性
J Org Chem. 2008 Feb 1;73(3):1018-24. doi: 10.1021/jo7020532. Epub 2008 Jan 4.
3
Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity.哌嗪羟肟酸类化合物的设计、合成及抗癌活性及其对组蛋白去乙酰化酶(HDAC)的抑制活性。
Bioorg Med Chem Lett. 2010 Jul 1;20(13):3906-10. doi: 10.1016/j.bmcl.2010.05.020. Epub 2010 May 15.
4
New aryldithiolethione derivatives as potent histone deacetylase inhibitors.新型芳基二硫代烯酮衍生物作为有效的组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem. 2010 Jun 15;18(12):4187-94. doi: 10.1016/j.bmc.2010.05.011. Epub 2010 May 7.
5
Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.鉴定出一系列取代的 2-哌嗪基-5-嘧啶基羟肟酸,它们是有效的组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):294-8. doi: 10.1016/j.bmcl.2009.10.118. Epub 2009 Oct 30.
6
Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor.新型组蛋白去乙酰化酶抑制剂N-羟基-7-(2-萘硫基)庚酰胺的抗肿瘤活性
Biochem Biophys Res Commun. 2007 Apr 27;356(1):233-8. doi: 10.1016/j.bbrc.2007.02.126. Epub 2007 Mar 2.
7
2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.具有N-羟基丙烯酰胺亚结构的2-芳酰基吲哚和2-芳酰基苯并呋喃作为一系列新型合理设计的组蛋白脱乙酰酶抑制剂。
J Med Chem. 2007 Sep 6;50(18):4405-18. doi: 10.1021/jm0703136. Epub 2007 Aug 11.
8
Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDAC inhibitors.新型二芳基醚类羟肟酸衍生物的合成及抗肿瘤活性研究作为潜在的 HDAC 抑制剂。
Arch Pharm Res. 2012 Oct;35(10):1723-32. doi: 10.1007/s12272-012-1003-0. Epub 2012 Nov 9.
9
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.新型组蛋白去乙酰化酶抑制剂3-(4-取代苯基)-N-羟基-2-丙烯酰胺的合成及生物学评价
J Med Chem. 2003 Dec 18;46(26):5745-51. doi: 10.1021/jm030377q.
10
Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges.泛组蛋白去乙酰化酶(pan-DAC)抑制剂帕比司他(LBH589)的研发:成功与挑战
Cancer Lett. 2009 Aug 8;280(2):233-41. doi: 10.1016/j.canlet.2009.02.019. Epub 2009 Apr 2.

引用本文的文献

1
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.天然组蛋白去乙酰化酶(HDAC)抑制剂作为抗癌药物的发现和发展进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):675-702. doi: 10.1007/s00210-023-02674-4. Epub 2023 Aug 24.
2
The diversity and utility of arylthiazoline and aryloxazoline siderophores: challenges of total synthesis.芳基噻唑啉和芳基恶唑啉铁载体的多样性与实用性:全合成面临的挑战
RSC Adv. 2022 Sep 7;12(39):25284-25322. doi: 10.1039/d2ra03841b. eCollection 2022 Sep 5.
3
Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.
基于哒嗪酮衍生物的首个c-Met/HDAC抑制剂的设计、合成及生物学评价
ACS Med Chem Lett. 2017 Jul 18;8(8):830-834. doi: 10.1021/acsmedchemlett.7b00172. eCollection 2017 Aug 10.
4
Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.作为新型抗癌药物模板的临床研究中的组蛋白去乙酰化酶抑制剂
Molecules. 2015 Mar 2;20(3):3898-941. doi: 10.3390/molecules20033898.
5
Histone deacetylase modulators provided by Mother Nature.天然来源的组蛋白去乙酰化酶调节剂。
Genes Nutr. 2012 Jul;7(3):357-67. doi: 10.1007/s12263-012-0283-9. Epub 2012 Feb 12.
6
Epigenetic changes induced by curcumin and other natural compounds.姜黄素和其他天然化合物诱导的表观遗传改变。
Genes Nutr. 2011 May;6(2):93-108. doi: 10.1007/s12263-011-0222-1. Epub 2011 Apr 24.
7
Syntheses and studies of amamistatin B analogs reveals that anticancer activity is relatively independent of stereochemistry, ester or amide linkage and select replacement of one of the metal chelating groups.阿米司他汀 B 类似物的合成与研究表明,抗癌活性相对独立于立体化学、酯或酰胺键以及金属螯合基团的选择性取代。
Bioorg Med Chem Lett. 2011 May 1;21(9):2611-5. doi: 10.1016/j.bmcl.2011.01.084. Epub 2011 Jan 22.
8
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.N-((1-苄基-1H-1,2,3-三唑-4-基)甲基)芳酰胺作为一种新的支架,为合成抗微管药物提供了快速途径:对选定癌细胞系的抗增殖活性的合成和评价。
J Med Chem. 2010 Apr 22;53(8):3389-95. doi: 10.1021/jm1000979.